Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

Author: Pal Sumanta  

Publisher: Springer Publishing Company

ISSN: 1776-2596

Source: Targeted Oncology, Vol.6, Iss.1, 2011-03, pp. : 5-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract